Source: StreetInsider

Press Release: Bio-Rad : Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz...

Read full article »
Annual Revenue
$1.0-5.0B
Employees
5.0-10K
Norman Schwartz's photo - Chairman & CEO of Bio-Rad

Chairman & CEO

Norman Schwartz

CEO Approval Rating

63/100

Read more